Insight Molecular Diagnostics Inc. (IMDX) stock news · rev $4.1M
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
This IMDX news page leads with what Insight Molecular Diagnostics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for IMDX yet. We will not pad this page with generic market recap.
Latest reported IMDX revenue for 2025-12-31 was $4.1M. Net income was -$50.2M. Revenue was up 115.6% from 2024-12-31 to 2025-12-31. IMDX currently screens at market cap $117.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMDX stock page; for the tape open the quote page.
IMDX stock news FAQ
What are IMDX's latest revenue and net income?
Latest cached Insight Molecular Diagnostics Inc. (IMDX) revenue for Dec 31, 2025 was $4.1M. Net income was -$50.2M. Statements: https://lician.com/financials/imdx
How did IMDX revenue change from the prior cached period?
Cached Insight Molecular Diagnostics Inc. (IMDX) revenue was up 115.6% from $1.9M (Dec 31, 2024) to $4.1M (Dec 31, 2025). Statements: https://lician.com/financials/imdx
What is IMDX's market cap?
Insight Molecular Diagnostics Inc. (IMDX) market cap is $117.1M on the latest cached fundamentals snapshot.
What kind of company is IMDX?
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Where is IMDX stock news listed?
Cached stock news for Insight Molecular Diagnostics Inc. (IMDX) is listed at https://lician.com/news/imdx. Filings: https://lician.com/sec/imdx
Not investment advice.